{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1206.56",
  "meta" : {
    "versionId" : "8",
    "lastUpdated" : "2024-07-19T01:06:46.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "Brigham and Women’s Hospital Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-07-19"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-07-19"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1206.56",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1206.56"
    }
  ],
  "version" : "20240719",
  "name" : "FOBT_Lab",
  "title" : "FOBT_Lab",
  "status" : "active",
  "date" : "2024-07-19T01:06:46-04:00",
  "publisher" : "Brigham and Women’s Hospital Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Data Element Scope: FOBT Lab),(Inclusion Criteria: The intent of this value set is for the purpose of defining the clinical codes that constitute FOBT Lab.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "concept" : [
          {
            "code" : "81528",
            "display" : "Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result"
          },
          {
            "code" : "82270",
            "display" : "Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)"
          },
          {
            "code" : "82274",
            "display" : "Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:bcc44ab8-e678-4b0c-b5a6-0c4132043d0f",
    "timestamp" : "2024-12-10T07:43:29-05:00",
    "total" : 3,
    "contains" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "81528",
        "display" : "Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "82270",
        "display" : "Blood, occult, by peroxidase activity (eg, guaiac), qualitative; feces, consecutive collected specimens with single determination, for colorectal neoplasm screening (ie, patient was provided 3 cards or single triple card for consecutive collection)"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "82274",
        "display" : "Blood, occult, by fecal hemoglobin determination by immunoassay, qualitative, feces, 1-3 simultaneous determinations"
      }
    ]
  }
}
